Alessandro Armuzzi is a Full Professor and Director of the Postgraduate Residency Program for Digestive System Diseases at IBD Center, Humanitas Research Hospital, Humanitas University, Milan, Italy. He gained his MD from the University of Bologna, Italy, and completed his internal medicine and gastroenterology training at the Catholic University of the Sacred Heart, Rome, Italy, before training in IBD at the John Radcliffe Hospital, Oxford, UK. His research includes genetics, diagnostic modalities to assess disease activity, clinical prediction and outcome, the design and conduct of multicentre real-world trials, and advanced therapy. His research interests focus on the genetics of IBD (past), diagnostic modalities to assess Crohn’s disease activity, clinical prediction and outcomes in clinical trials, and biologic therapy in IBD. He serves as a member of several gastroenterology associations (Italian Group for the Study of Inflammatory Bowel Disease; Scientific Committee of the Italian Society of Gastroenterology), as Chair of the ClinCom of ECCO, and he has authored many IBD publications.